YIA
CRL icon

YHB Investment Advisors’s Charles River Laboratories CRL Stock Holding History

YHB Investment Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-941
Closed -$255K – 278
2024
Q1 		$255K Hold
941
– – 0.02% 246
2023
Q4 		$222K Sell
941
-101
-10% -$19.9K 0.02% 250
2023
Q3 		$204K Buy
1,042
+7
+0.7% +$1.44K 0.02% 261
2023
Q2 		$218K Hold
1,035
– – 0.02% 266
2023
Q1 		$209K Hold
1,035
– – 0.02% 276
2022
Q4 		$226K Hold
1,035
– – 0.02% 266
2022
Q3 		$204K Buy
+1,035
New +$223K 0.02% 273

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

YHB Investment Advisors's CRL Position: Q2 2024 in Review

YHB Investment Advisors sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 941 shares — an estimated $255K sold.

YHB Investment Advisors first reported a position in CRL in Q3 2022 and held it in 7 quarters. The position peaked at $255K in Q1 2024. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • YHB Investment Advisors reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • YHB Investment Advisors sold 941 Charles River Laboratories shares in Q2 2024, an estimated $255K.
  • YHB Investment Advisors first reported a position in Charles River Laboratories in Q3 2022 and held it in 7 quarters.
  • YHB Investment Advisors's Charles River Laboratories position peaked at $255K in Q1 2024.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on YHB Investment Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.